AU2002251202A1 - Intimins for the prevention or treatment of infections: i - Google Patents

Intimins for the prevention or treatment of infections: i

Info

Publication number: AU2002251202A1
Authority: AU; Australia
Prior art keywords: intimins; infections; prevention; treatment
Prior art date: 2001-03-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002251202A

Inventor

Gordon Dougan

Gadi Frankel

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ip2ipo Innovations Ltd

Original Assignee

Imperial College Innovations Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-29

Filing date

2002-03-26

Publication date

2002-10-15

2001-03-29 Priority claimed from GB0107840A external-priority patent/GB0107840D0/en

2001-03-29 Priority claimed from GB0107837A external-priority patent/GB0107837D0/en

2002-03-26 Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd

2002-10-15 Publication of AU2002251202A1 publication Critical patent/AU2002251202A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AU2002251202A 2001-03-29 2002-03-26 Intimins for the prevention or treatment of infections: i Abandoned AU2002251202A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0107840A GB0107840D0 (en)	2001-03-29	2001-03-29	Biological materials and methods for use in the prevention or treatment of infections:I
GB0107837A GB0107837D0 (en)	2001-03-29	2001-03-29	Biological materials and methods for use in the prevention or treatment of infections:II
GB0107840.1		2001-03-29
GB0107837.7		2001-03-29
PCT/GB2002/001447 WO2002079240A2 (en)	2001-03-29	2002-03-26	Intimins for the prevention or treatment of infections: i

Publications (1)

Publication Number	Publication Date
AU2002251202A1 true AU2002251202A1 (en)	2002-10-15

Family

ID=26245909

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2002251202A Abandoned AU2002251202A1 (en)	2001-03-29	2002-03-26	Intimins for the prevention or treatment of infections: i
AU2002241162A Abandoned AU2002241162A1 (en)	2001-03-29	2002-03-26	Intimins in the prevention or treatment of infections:ii

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2002241162A Abandoned AU2002241162A1 (en)	2001-03-29	2002-03-26	Intimins in the prevention or treatment of infections:ii

Country Status (3)

Country	Link
EP (1)	EP1372709A2 (en)
AU (2)	AU2002251202A1 (en)
WO (2)	WO2002079240A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1305525C (en) *	2004-03-27	2007-03-21	中国人民解放军第三军医大学	0157 bacterium gene engineering multivalence subunit vaccine of human and sensitive animals and its preparing method
GB2473523A (en) *	2009-09-10	2011-03-16	Solus Scient Solutions Ltd	Nalidixic acid and lithium in a base medium for the culture of Listeria
CN103212060B (en) *	2013-04-23	2014-11-05	中国人民解放军军事医学科学院微生物流行病研究所	Application of protein and composition thereof in preparation of product used for preventing, diagnosing or treating EHEC (Enterohemorrhagic Escherichia Coli) infection
CN105821065A (en) *	2016-04-29	2016-08-03	南方医科大学	Double-antigen recombinant protein and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2252438C (en) *	1996-04-19	2011-03-29	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
DE69736226T2 (en) *	1996-04-19	2006-11-09	Henry M. Jackson Foundation For The Advancement Of Military Medicine	METHOD FOR ENGAGING AN IMMUNE RESPONSE BY ADMINISTRATION OF UTILITIES EXPRESSING INTIMIN ALONE OR AS A FUSION PROTEIN WITH ONE OR MORE OTHER ANTIGENES
GB9803322D0 (en) *	1998-02-16	1998-04-15	Imperial College	Methods
GB9901897D0 (en) *	1999-01-29	1999-03-17	Imp College Innovations Ltd	Biological material and use thereof
CA2433792C (en) *	2001-01-04	2012-03-27	University Of Saskatchewan	Enterohemorragic escherichia coli vaccine

2002
- 2002-03-26 AU AU2002251202A patent/AU2002251202A1/en not_active Abandoned
- 2002-03-26 AU AU2002241162A patent/AU2002241162A1/en not_active Abandoned
- 2002-03-26 WO PCT/GB2002/001447 patent/WO2002079240A2/en not_active Ceased
- 2002-03-26 WO PCT/GB2002/001462 patent/WO2002079247A2/en not_active Ceased
- 2002-03-26 EP EP02720132A patent/EP1372709A2/en not_active Withdrawn

Also Published As

Publication number	Publication date
AU2002241162A1 (en)	2002-10-15
EP1372709A2 (en)	2004-01-02
WO2002079247A2 (en)	2002-10-10
WO2002079240A3 (en)	2003-06-26
WO2002079240A2 (en)	2002-10-10
WO2002079247A3 (en)	2003-10-30

Similar Documents

Publication	Publication Date	Title
GB0125222D0 (en)	2001-12-12	Composition for the treatment of microbial infections
AU2002310325A1 (en)	2002-12-23	Use of ozone for the prevention of infection caused by medical devices
IL160187A0 (en)	2004-07-25	Aerosolized decongestants for the treatment of sinusitis
AU2003901008A0 (en)	2003-03-20	Composition for the treatment and prevention of bacterial infections
AU2002342613A1 (en)	2002-11-25	Treatment for wounds
AU2001272852A1 (en)	2002-01-21	Composition for the treatment of migraine
AU2002303502A1 (en)	2002-11-11	Improved leads for the treatment of patients with chf
AU2002356868A1 (en)	2003-05-12	Methods for the prevention or treatment of bacterial and fungal infections
AU2002240359A1 (en)	2002-08-28	Pharmaceutical composition for the treatment of alopecia
AU2003258145A1 (en)	2004-02-25	Substituted phenylindoles for the treatment of hiv
AU2001269704A1 (en)	2002-01-21	Oxazinoquinolones useful for the treatment of viral infections
AU2003291886A1 (en)	2004-06-30	Thiophenederivatives for the treatment of flavivirus infections
AU2002236781A1 (en)	2002-07-30	Treatment for snoring
AU2002322082A1 (en)	2003-01-02	Pharmaceutical composition for the treatment of viral infection
AU2002249947A1 (en)	2002-07-30	Inhibition of protein-phosphatases for the treatment of heart failure
AU2003301012A1 (en)	2004-07-09	Use of beta-defensins for treating hiv infections
AU2002251202A1 (en)	2002-10-15	Intimins for the prevention or treatment of infections: i
AU2001258675A1 (en)	2001-11-26	Treating infections
AU2003263978A1 (en)	2004-02-23	2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections
AU2002302580A1 (en)	2002-11-11	Use of phyllanthus constituents for treating or preventing infections caused by hepatit
AU2002249891A1 (en)	2002-07-16	Compounds and methods for the diagnosis and treatment of babesia infection
AU2002354372A1 (en)	2003-06-17	Installation for the treatment of products in bulb or tuber form
AU2003240174A1 (en)	2003-12-22	Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2002304733A1 (en)	2002-10-28	Amino-aza-cyclohexanes for the treatment of malaria
AU2002344855A1 (en)	2002-12-23	Compounds and methods for the treatment or prevention of flavivirus infections

Legal Events

Date	Code	Title	Description
2004-02-19	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase